Model Cutoff Patients HVPG-proved CSPH patients Performance
CSPH risk model (n=151) Rule out CSPH risk <-0.68
53 (35.1%)
5
SE: 93.6% NPV: 90.6%
Grey zone 34 (22.5%) 15 50.0% of patients with CSPH
Rule in CSPH risk >0
64 (42.3%)
58
SP: 91.8% PPV: 90.6%
Baveno VII criteria (n=151) Rule out LSM ≤15 kPa and PLT ≥150×109/L
46 (30.4%)
3
SE: 96.9% NPV: 94.6%
Grey zone 76 (50.3%) 48 63.1% of patients with CSPH
Rule in LSM ≥25 kPa
29 (19.2%)
27
SP: 98.2% PPV: 96.0%